|
2025
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A... |
|
|
G/S
|
Medical and scientific research in the field of obesity |
|
|
G/S
|
5: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia... |
|
|
G/S
|
Medical information services, namely providing information related to healthcare and diseases and... |
|
|
G/S
|
Medical information services in the field of alopecia, Alzheimer's disease, atopic dermatitis, au... |
|
|
G/S
|
Medical and scientific research in the field of endocrine diseases and disorders and metabolic di... |
|
|
G/S
|
Medical and scientific research in the field of blood diseases and disorders and cancer |
|
|
G/S
|
Medical and scientific research in the field of metabolic, endocrine and Alzheimer’s disease |
|
|
G/S
|
Software application for verifying the authenticity of pharmaceutical products; software for scan... |
|
|
Invention
|
Sodium-hydrogen exchanger 3 inhibitor compounds.
The present invention relates to sodium-hydroge... |
|
|
Invention
|
Medication delivery device with dose detection system.
The present disclosure relates to a medic... |
|
|
Invention
|
Medication delivery device including disposable and reusable portions.
A medication delivery dev... |
|
|
Invention
|
Gip/glp1 agonist compositions.
A composition of tirzepatide, comprising an agent selected from N... |
|
|
Invention
|
Process for preparing a gip/glp1 dual agonist.
The present invention provides novel intermediate... |
|
|
Invention
|
Glucagon receptor agonists with aryl linkers and their use as therapies. Disclosed herein is a co... |
|
|
Invention
|
Incretin analogs and uses thereof.
Incretin analogs are provided that have activity at each of t... |
|
|
Invention
|
Novel oligonucleotides bearing a "2-propyl" internucleoside linkage. Disclosed herein are nucleic... |
|
|
Invention
|
Novel rna therapeutics and uses thereof. The present disclosure relates to novel therapeutic comp... |
|
|
Invention
|
Inhbe rna interference agents. The present invention relates to novel therapeutic compounds, know... |
|
|
Invention
|
Novel rna therapeutics and uses thereof. The present invention relates to novel therapeutic compo... |
|
|
Invention
|
Stable apo-active complex of a g protein coupled receptor (gpcr) and a g protein. Disclosed herei... |
|
|
Invention
|
Prnp rnai agents. Provided herein are PRNP RNAi agents and compositions comprising a PRNP RNAi ag... |
|
|
Invention
|
Gip receptor agonist compounds. The present disclosure provides compounds of the Formula (IX), an... |
|
|
Invention
|
Prnp rnai agents.
Provided herein are PRNP RNAi agents and compositions comprising a PRNP RNAi a... |
|
|
Invention
|
Glucocorticoid receptor agonists.
The present invention provides a compound of Formula I:
The ... |
|
|
Invention
|
Dropout detection techniques. A method is provided for filtering a signal received from a sensor ... |
|
|
Invention
|
Compositions and methods for improving insulin sensitivity. The present disclosure relates to com... |
|
|
Invention
|
Glp-1 npa therapies for maintaining body weight loss or reduced hba1c levels following a prior gl... |
|
|
Invention
|
Conveyor belt design and puck number optimization in manufacturing network. A system for manufact... |
|
|
Invention
|
Activation of egfr/her2/3 in cancer after treatment with an inhibitor of fibroblast growth factor... |
|
|
Invention
|
Formulations for anti-n3pglu amyloid beta antibodies. The present disclosure is related to stable... |
|
|
Invention
|
Acvr2a and acvr2b rna interference agents. Provided herein are Activin Receptor type 2A (ACVR2A) ... |
|
|
Invention
|
Transferrin receptor (tfr)-binding variable domains of a heavy chain only antibody (vhh), conjuga... |
|
|
Invention
|
Pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insul... |
|
|
Invention
|
System and method for testing damping material. Systems and methods are disclosed for testing the... |
|
|
Invention
|
4-phenyl-1h-pyrazolo[3,4-b]pyridine-5-carboxamide derivatives as amylin and/or calcitonin recepto... |
|
|
Invention
|
Devices for drug delivery. A drug delivery device includes a housing, a needle, and a pressure ch... |
|
|
Invention
|
Rxfp1 receptor agonists. a bb are as described herein, pharmaceutically acceptable salts thereof,... |
|
|
Invention
|
Endocrine therapy and abemaciclib combination for the adjuvant treatment of node-positive, early ... |
|
|
Invention
|
Button for injection device. Medication delivery devices having a dosage button which may be tran... |
|
|
Invention
|
Processes for preparing enantiomeric compounds and related molecules. The present disclosure rela... |
|
|
Invention
|
Protein tyrosine kinase 7 antibodies and antibody-drug conjugates.
The present disclosure provid... |
|
|
Invention
|
Protein tyrosine kinase 7 antibodies and antibody-drug conjugates. The present disclosure provide... |
|
|
Invention
|
Lipid nano delivery particles for targeted transport of nucleic acids and methods of making and u... |
|
|
Invention
|
Substituted 1,1'-biphenyl compounds as glucagon receptor agonists. Disclosed herein is a compound... |
|
|
Invention
|
Glucagon receptor agonists and their use as therapies. Disclosed herein is a compound of formula ... |
|
|
Invention
|
Baffr x cd3 bispecific antibodies and methods of use. The present invention relates to antibodies... |
|
|
Invention
|
Compositions and methods for treating metabolic diseases. The invention provides compositions and... |
|
2024
|
Invention
|
Anti-cd137 antibodies for combination with anti-pd-1 antibodies.
The present invention relates t... |
|
|
Invention
|
Display screen with animated graphical user interface |
|
2023
|
Invention
|
Novel rna therapeutics and uses thereof.
The present invention relates to novel therapeutic comp... |
|
|
Invention
|
Oral drug delivery device with expanding arms.
The present disclosure provides a drug delivery d... |
|
|
Invention
|
Box |
|
|
Invention
|
Methods of using neuregulin-4 compounds.
The present invention relates to doses and dosing regim... |
|
|
Invention
|
Ingestible capsule device.
The techniques provide for non-invasive gastrointestinal sampling. In... |
|
|
Invention
|
Glp1 tablet compositions.
Disclosed herein is a tablet composition comprising 3-[(1S,2S)-1-[5-[(... |
|
|
Invention
|
Tablet |
